Petros Pharmaceuticals, Inc.
PTPI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $79,056 | $45,326 | $120,590 | $906,573 |
| - Cash | $3,710 | $13,337 | $9,426 | $23,848 |
| + Debt | $7,386 | $8,277 | $9,883 | $405 |
| Enterprise Value | $82,733 | $40,266 | $121,046 | $883,131 |
| Revenue | $5,112 | $5,822 | $5,992 | $7,811 |
| % Growth | -12.2% | -2.8% | -23.3% | – |
| Gross Profit | $3,899 | $4,191 | $3,703 | $6,212 |
| % Margin | 76.3% | 72% | 61.8% | 79.5% |
| EBITDA | -$10,814 | -$4,212 | -$13,726 | -$1,740 |
| % Margin | -211.5% | -72.3% | -229.1% | -22.3% |
| Net Income | -$14,319 | -$8,163 | -$20,038 | -$8,987 |
| % Margin | -280.1% | -140.2% | -334.4% | -115% |
| EPS Diluted | -3.34 | -6.35 | -9.68 | -8.25 |
| % Growth | 47.4% | 34.4% | -17.3% | – |
| Operating Cash Flow | -$2,603 | -$7,627 | -$12,797 | -$11,862 |
| Capital Expenditures | -$25 | $0 | $0 | $0 |
| Free Cash Flow | -$2,628 | -$7,627 | -$12,797 | -$11,862 |